|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses | |||||
| Research and technical expenses | |||||
| Restructuring and other (income) charges, net | |||||
| Goodwill impairment charge | |||||
| Long lived asset impairment charge | |||||
| Acquisition-related costs | |||||
| Other (income) expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Provision (benefit) for income taxes on continuing operations | |||||
| Net income (loss) from continuing operations | |||||
| Income (loss) from discontinued operations, net of income taxes | |||||
| Net income (loss) | |||||
| Per share data | |||||
| Basic earnings (loss) per share from continuing operations (usd per share) | |||||
| Basic earnings (loss) per share (usd per share) | |||||
| Diluted earnings (loss) per share from continuing operations (usd per share) | |||||
| Diluted earnings (loss) per share from discontinued operations (usd per share) | |||||
| Diluted earnings (loss) per share (usd per share) |
Loading...
